NeOnc Technologies Holdings is trading at $4.69, down 5.06%, as risk-off sentiment pressures biotech and growth stocks.
- U.S. indexes are lower amid elevated bond yields, rising oil prices, and renewed Middle East tensions; Reuters reported the Nasdaq opened down 1.29% and the S&P 500 down 0.66% on September 1, 2026.
- Available company coverage remains focused on the positive NEO100 Phase 2a results reported August 12, not a new September 1 announcement.